Reps and Warranties Insurance in Healthcare Transactions: Shifting Liability Risks
Evaluating When Insurance is Appropriate, Negotiating Coverage and Exclusions
Recording of a 90-minute CLE webinar with Q&A
This CLE webinar will guide healthcare counsel on the use of representation and warranties insurance in healthcare transactions. The panel will examine when such insurance is appropriate, how it can be best utilized, and what should be covered. The panel will offer best practices for leveraging reps and warranties insurance in healthcare transactions.
- Rep and warranty insurance in healthcare transactions
- When is it appropriate?
- How can it be utilized?
- What should be covered?
- Principal considerations when determining to use rep and warranty insurance
- Best practices for structuring and negotiating rep and warranty insurance
The panel will review these and other key issues:
- What are the potential benefits and pitfalls associated with rep and warranty insurance in healthcare transactions?
- How can rep and warranty insurance be used to mitigate risk and complete transactions?
- What are some of the critical issues when negotiating rep and warranty insurance coverage and exclusions?
Morgan Lewis & Bockius
Mr. Chan has more than 15 years of experience advising companies on M&As, private equity, growth equity, and... | Read More
Mr. Chan has more than 15 years of experience advising companies on M&As, private equity, growth equity, and venture capital transactions, as well as on corporate governance, emerging company representation, and corporate finance. His clients include strategic buyers and sellers as well as financial sponsors and their portfolio companies in the life sciences, investment management, technology, and video game sectors. He also regularly advises on complex international and cross-border matters. Mr. Chan serves as an adjunct professor at Georgetown Law School where he teaches Takeovers, Mergers and Acquisitions.Close
Curtis R. Hearn
Mr. Hearn has served as co-lead of the firm’s Corporate Practice Group for 20 years. He has represented buyers... | Read More
Mr. Hearn has served as co-lead of the firm’s Corporate Practice Group for 20 years. He has represented buyers and sellers in public and private transactions involving the acquisition of hospitals and hospital groups; purchase and sale of managed healthcare plans; and purchase of companies in ancillary healthcare services such as radiology and imaging. Mr. Hearn has also been lead counsel on complex healthcare joint ventures. He provides sophisticated guidance at the leading edge of emerging market and regulatory developments, with an emphasis on companies in the energy, healthcare, manufacturing, and logistics industries.Close
Stephanie Winer Schreiber
Buchanan Ingersoll & Rooney
Ms. Schreiber focuses her practice on substantial M&A transactions, joint ventures, general corporate matters,... | Read More
Ms. Schreiber focuses her practice on substantial M&A transactions, joint ventures, general corporate matters, corporate reorganizations, governance issues, and compliance and regulatory matters. Within the healthcare arena, in addition to her extensive experience in M&A, Ms. Schreiber actively assists clients in structuring complex joint venture transactions, negotiating provider and professional services agreements, and organizing health information exchanges. She is an adjunct professor at the University of Pittsburgh School of Law and a frequent lecturer on healthcare M&As and other topics.Close